Bibliography
- Weinshilboum RM , RaymondFA, PazminoPA: Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties.Clin. Chim. Acta85 , 323–333 (1978).
- Krynetski EY , TaiHL, YatesCR, FessingMY, LoennechenT, SchuetzJD: Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms.Pharmacogenetics6 , 279–290 (1996).
- Weinshilboum R : Inheritance and drug response.N. Engl. J. Med.348(6) , 529–537 (2003).
- Weinshilboum RM , SladekSL: Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.Am. J. Hum. Genet.32 , 651–662 (1980).
- Dokmanovic L , UrosevicJ, JanicD et al.: Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia.Ther. Drug Monit.28 , 800–806 (2006).
- Spire-Vayron de la Moureyre C , DebuysereH, FazioF et al.: Characterization of variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter.Pharmacogenetics9 , 189–198 (1999).
- Roberts RL , GearryRB, BlandMV et al.: Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity.Pharmacogenet. Genomics18 , 434–438 (2008).
- Spire-Vayron de la Moureyre C , DebuysereH, MastainB et al.: Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in European population.Br. J. Pharmacol.125 , 879–887 (1998).
- Yan L , ZhangS, EiffB et al.: Thiopurine methyltransferase polymorphic tandem repeat: genotype–phenotype correlation analysis.Clin. Pharmacol. Ther.68(2) , 210–219 (2000).
- Kham SK , SohCK, AwDC, YeohAE: TPMT*26 (208F-->L), a novel mutation detected in a Chinese.Br. J. Clin. Pharmacol.68 , 120–123 (2009).
- Krynetski EY , FessingMY, YatesCR, SunD, SchuetzJD, EvansWE: Promoter and intronic sequences of the human thiopurine S-methyltransferase (TPMT) gene isolated from a human PAC1 genomic library.Pharm. Res.14 , 1672–1678 (1997).
- Fessing MZ , KrynetskiEY, ZambethiGP, EvansWE: Functional characterization of the human thiopurin methyltransferase gene promoter.Eur. J. Biochem.256 , 510–517 (1998).
- Marinaki AM , ArenasM, KhanZH et al.: Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians.Pharmacogenetics13 , 97–105 (2003).
- Alves S , AmorimA, FerreiraF, PrataMJ: Pharmacogenetics and genomics: influence of the variable number of tandem repeats located in the promoter region of the thiopurine methyltransferase gene on enzymatic activity.Clin. Pharmacol. Ther.70 , 165–174 (2001).
- Boshart M , KlüppelM, SchmidtA, SchützG, LuckowB: Reporter constructs with low background activity utilizing the cat gene.Gene110 , 129–130 (1992).
- Papachatzopoulou A , KaimakisP, PourfarzadF et al.: Increased γ-globin gene expression in β-thalassemia intermedia patients correlates with a mutation in 3´HS1.Am. J. Hematol.82 , 1005–1009 (2007).
- Alves S , AmorimA, Joao Prata M: Evolution of a VNTR located within the promoter region of the thiopurine methyltransferase gene: inferences from population and sequenced data. Hum. Genet.111 , 172–178 (2002).
- Fabre MA , JonesDC, BunceM et al.: The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.Transpl. Int.17 , 531–539 (2004).
- Cartharius K , FrechK, GroteK et al.: MatInspector and beyond: promoter analysis based on transcription factor binding sites.Bioinformatics21 , 2933–2942 (2005).
- Chen BS , HampseyM: Transcription activation: unveiling the essential nature of TFIID.Curr. Biol.12 , 620–622 (2002).
- van Loon JA , WeinshilboumRM: Human lymphocyte thiopurine methyltransferase pharmacogenetics: effect of phenotype on 6-mercaptopurine-induced inhibition of mitogen stimulation.J. Pharmacol. Exp. Ther.242 , 21–26 (1987).
- Dervieux T , BlancoJG, KrynetskiEY, VaninEF, RousselMF, RellingMV: Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.Cancer Res.61 , 5810–5816 (2001).
- Coulthard SA , HogarthLA, LittleM et al.: The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs.Mol. Pharmacol.62 , 102–109 (2002).
- Arenas M , DuleyJA, AnsariA: Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype.Nucleosides Nucleotides Nucleic Acids23 , 1403–1405 (2004).
- Pruzina S , HanscombeO, WhyattD, GrosveldF, PhilipsenS: Hypersensitive site 4 of the human β-globin locus control region.Nucleic Acids Res.19 , 1413–1418 (1991).